• Cy5 NHS ester(Et): Technical Guide for Fluorescent Labeling

  2026-06-15

  Cy5 NHS ester(Et) enables efficient, water-soluble fluorescent labeling of amino groups in proteins and biomolecules, supporting applications such as immunofluorescence staining, flow cytometry, and fluorescence microscopy. It is not suitable for ethanol-based protocols or workflows requiring long-term storage of dye solutions, ensuring optimal performance only when handled according to recommended procedures.

• Astrocytic GAT-3 Modulation of Dentate Gyrus Synaptic Transm

  2026-06-14

  This study reveals that astrocytic GAT-3 governs synaptic transmission and memory formation in the dentate gyrus by linking GABA uptake to astrocytic calcium signaling. These findings advance understanding of glia-mediated neurotransmitter regulation and inform new avenues for synaptic transmission research.

• Phosphotungstic Acid Negative Stain Solution (2%): Transform

  2026-06-13

  Discover how Phosphotungstic Acid Negative Stain Solution (2%) enables nuanced electron microscopy of viruses, bacteria, and macromolecules. This article explores advanced staining mechanisms, bridges breakthrough glycan-targeting findings to real-world imaging decisions, and sets a new benchmark for research rigor.

• Rucaparib (AG-014699): Mechanistic Leverage in DNA Repair Re

  2026-06-12

  Explore how Rucaparib (AG-014699) redefines DNA damage response strategies in translational research. This article integrates cutting-edge mechanistic insights, including recent discoveries around RNA Pol II-mediated apoptosis, with actionable guidance on protocol optimization and workflow design. APExBIO’s Rucaparib is positioned not just as a tool compound, but as a strategic asset for next-generation cancer biology and precision oncology.

• Tofacitinib Citrate in JAK-STAT Research: Mechanisms & Assay

  2026-06-12

  Explore how tofacitinib citrate (CP-690550 citrate) advances JAK-STAT signaling and immune regulation research, with a deep dive into recent cardiovascular findings and assay design implications. Discover unique mechanistic insights and best practices for effective experimental use.

• gamma-Glu-Cys (γ-Glu-Cys): Protocols and Workflow Guidance

  2026-06-11

  gamma-Glu-Cys (γ-Glu-Cys) is a high-purity substrate essential for glutathione metabolism research and peptide synthesis workflows, especially for studies involving glutathione synthetase activity or plant stress adaptation. It should be used strictly in scientific research settings, not for diagnostic or clinical purposes, and is best suited where precise substrate quality and workflow reproducibility are critical.

• Elobixibat Hydrate: Selective IBAT Inhibitor for GI Disorder

  2026-06-11

  Elobixibat hydrate is a selective ileal bile acid transporter (IBAT) inhibitor used to treat chronic idiopathic constipation and metabolic abnormalities in type 2 diabetes mellitus. Its highly specific mechanism increases colonic bile acids, activating TGR5 and GLP-1 pathways. The compound shows clinically verified improvements in bowel function and metabolic markers.

• Allosteric Aptamer Biosensor Enables Live Tracking of Native

  2026-06-10

  This study introduces a genetically encoded allosteric biosensor that allows real-time, high-specificity visualization of endogenous protein dynamics in living cells. The approach overcomes artifacts associated with overexpression or genetic modification, providing a robust platform for studying native protein localization and abundance.

• Homoharringtonine Rapidly Clears SARS-CoV-2 in Preclinical M

  2026-06-10

  The reference study demonstrates that homoharringtonine, a cytotoxic alkaloid previously used in cancer research, can achieve rapid SARS-CoV-2 clearance in both animal models and clinical cohorts. These findings highlight a promising cross-domain antiviral strategy, with implications for future coronavirus epidemic preparedness.

• Tin Mesoporphyrin IX: Precision Heme Oxygenase Inhibition in

  2026-06-09

  Tin Mesoporphyrin IX (chloride) delivers nanomolar-precision inhibition of heme oxygenase, enabling robust assay reproducibility in metabolic disease and virology research. Its in vivo efficacy at ultra-low doses and versatility across experimental models set a new benchmark for targeted heme catabolism studies.

• GPNMB Biomarker Model Predicts Immunotherapy Response in ESC

  2026-06-09

  This study introduces a multimodal model based on circulating GPNMB to predict immunotherapy outcomes in esophageal squamous cell carcinoma (ESCC). By elucidating the tumor–immune interactions driving CD8+ T cell exhaustion, the work provides robust, clinically relevant biomarkers for patient stratification and precision oncology applications.

• 1-Phenyl-2-Pentanol from Moringa Inhibits Hepatic Stellate A

  2026-06-08

  This study identifies 1-phenyl-2-pentanol (1-PHE) from Moringa oleifera as a potent inhibitor of hepatic stellate cell activation, with anti-fibrotic effects mediated by TGF-β1 and Wnt/β-catenin pathway modulation. The findings provide mechanistic insight for liver fibrosis research and inform the refinement of in vitro anti-fibrotic models.

• FPR2/ALX Agonism Modulates Microglia to Limit CNS Autoimmuni

  2026-06-08

  The reference study demonstrates that stimulating FPR2/ALX with Quin-C1 restricts neuroinflammation and demyelination in a mouse model of autoimmune astrocytopathy. By dissecting the roles of microglia and NK cells via the SYK-AKT pathway, the research identifies a novel immunomodulatory strategy potentially relevant for diseases such as NMOSD.

• LY2109761: TGF-β Receptor Type I/II Dual Inhibitor in Tumor

  2026-06-07

  LY2109761 stands out as a highly selective TGF-β receptor type I and II dual inhibitor, enabling precise modulation of Smad2/3 signaling in cancer and fibrosis research. Its robust inhibition, radiosensitization, and anti-invasion properties make it a flexible tool for translational workflows in glioblastoma and pancreatic cancer studies.

• gamma-Glu-Cys (γ-Glu-Cys): Mechanistic Insights and Strategi

  2026-06-06

  Explore how gamma-Glu-Cys (γ-Glu-Cys) transforms glutathione metabolism research with a focus on mechanistic detail, assay optimization, and recent advances in γ-glutamyl peptide production. Discover unique applications and evidence-based guidance for leveraging this essential intermediate.

14872 records 2/992 page Previous Next 12345 下5页 Last page